nice one sav,
That would be Dr Stephen Griffin, PhD in virology from Cambridge University.
He seems to think drugs like BIT225 would be a fine fit with the new classes of HCV drugs.
Hey, rgc68, what's your opinion? You still think BIT225 isn't attractive as part of a cocktail therapy along with protease or polymerase inhibitors?
I'm just a layman, but clearly Dr Griffin is not.
nice one sav,That would be Dr Stephen Griffin, PhD in virology...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $5.671K | 298.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 512798 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1050263 | 5 |
View Market Depth
| Last trade - 15.59pm 04/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |